Microbiome Archives

News and Trends 5 Jan 2023

2023 Editorial Calendar updated

Each month here at Labiotech.eu, we produce a special newsletter. While still news-related, these special editions are an opportunity to take a deeper look at topics of interest. It also allows us to focus on some of the special awareness days – of which there are many – associated with health and the life sciences. […]

January 5, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 21 Dec 2022

Biomica raises $20M to advance microbiome-based therapeutics pipeline

Biomica Ltd., a subsidiary of Evogene Ltd., has signed a definitive agreement for a $20 million financing round, to be led by Shanghai Healthcare Capital (SHC). The financing is subject to customary closing conditions, including clearance by Chinese regulatory authorities. The financing round will enable Biomica to develop its pipeline of microbiome-based therapeutics. The company […]

December 21, 2022 - 2 minutesmins - By Jim Cornall

Interview 5 Dec 2022

Interview: why the recently approved fecal microbiome product is causing a rumble

The news last week of the FDA approving Ferring Pharmaceuticals’ first fecal microbiome product, Rebyota, caused quite a stir in the field. The news was described as a huge step, a giant leap forward and simply fantastic. Paul Feurstadt is the director of non-inflammatory bowel disease research at the Medical Research Center of Connecticut. He also […]

December 5, 2022 - 5 minutesmins - By Liza Laws

News and Trends 1 Dec 2022

FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field

The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA) today has been hailed ‘fantastic news’ by those in the microbiome field. Ferring Pharmaceutical’s product is approved to stop Clostridiodes difficile infection (CDI) in people over 18 and to be given after they have completed an antibiotic treatment for the […]

December 1, 2022 - 6 minutesmins - By Liza Laws

Interview 14 Nov 2022

MaaT Pharma: leading the charge in microbiome therapeutics

The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business officer at the French biotech MaaT Pharma outlines the firm’s efforts to blaze a trail in clinical testing and manufacturing in the new field. The microbiome world recently made a regulatory step forward as Australia greenlit a stool transplant developed […]

November 14, 2022 - 5 minutesmins - By Jonathan Smith

Persephone Bisociences Microbiome health

Startup Scout 28 Oct 2022

Persephone Biosciences studies the microbiome in baby poop

Disruption in the gut microbiome is linked to a wide range of health problems in newborn babies and patients with cancer. Persephone Biosciences is studying stool samples from these populations to devise bacterial treatments that improve gut health. Research into the gut microbiome has advanced a long way in the last decades. One major boost […]

October 28, 2022 - 6 minutesmins - By Jonathan Smith

Anastasiia Slynko neobe therapeutics cancer

Startup Scout 19 Oct 2022

Neobe Therapeutics breaks down tumor defenses with bacteria

Many cancer patients cannot benefit from cancer immunotherapy because their tumors are protected from the immune system. Neobe Therapeutics’ bacterial therapy is designed to strip the tumors of their protective barriers. The immune system is very good at fighting tumors, and cancer immunotherapies are often able to supercharge our natural defenses to great effect. However, […]

October 19, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 17 Oct 2022

Clinical Microbiomics acquires MS-Omics

Clinical Microbiomics, a microbiome research company, has acquired MS-Omics, a metabolomics provider based in Denmark. Clinical Microbiomics works on clonal-level microbiome profiling. With the acquisition, Clinical Microbiomics adds expertise in metabolite profiling from MS-Omics to further advance its systems biology platform and help researchers worldwide understand the microbiome and how to impact health and disease. […]

October 17, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 13 Oct 2022

Skin microbiome research could lead to new approaches for addressing organ damage after stem cell transplants

Skin microbiome research could lead to new approaches for addressing organ damage after stem cell transplants. Organ damage occurs in up to 70% of patients in the first few months following stem cell transplant. The reasons for this potentially life-threatening reaction have long been the subject of scientific research. Now, researchers led by Georg Stary […]

October 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 11 Oct 2022

License granted to EnteroBiotix for manufacture of microbiome product candidates

Microbiome therapeutics company, EnteroBiotix Limited has been granted a manufacturer’s license for a GMP manufacturing facility for Investigational Medicinal Products (IMP) to make microbiome product candidates for clinical trials. It was given by the Medicines and Healthcare Products Regulatory Agency (MHRA) and also incorporates an in-house QC hub and analytical department. EnteroBiotix’s manufacturing capabilities include […]

October 11, 2022 - 2 minutesmins - By Liza Laws

News and Trends 11 Oct 2022

Clinical Microbiomics expanding with €10M million investment

Danish microbiome research company Clinical Microbiomics A/S has received €10 million ($9.7 million) in funding from Seventure Partners. Clinical Microbiomics, founded in 2015, is a microbiome analysis company, which includes work on clonal-level microbiome profiling. The company is working with food and consumer health companies and is supporting the pharmaceutical industry in phase 3 clinical […]

October 11, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 15 Sep 2022

Novome Biotechnologies raises $43.5M for therapeutically engineered microbes pipeline

U.S. biotech company Novome Biotechnologies, Inc., has closed a $43.5 million series B financing round. The financing was led by Tencent, and includes new investors University of Minnesota, Navian Investments, Colorcon Ventures and Touchdown Ventures. Existing investors DCVC Bio, 5AM Ventures, Alta Partners and Alexandria Venture Investments also participated. The proceeds will be used to […]

September 15, 2022 - 3 minutesmins - By Jim Cornall

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Microbiome

2023 Editorial Calendar updated

Biomica raises $20M to advance microbiome-based therapeutics pipeline

Interview: why the recently approved fecal microbiome product is causing a rumble

FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field

MaaT Pharma: leading the charge in microbiome therapeutics

Persephone Biosciences studies the microbiome in baby poop

Neobe Therapeutics breaks down tumor defenses with bacteria

Clinical Microbiomics acquires MS-Omics

Skin microbiome research could lead to new approaches for addressing organ damage after stem cell transplants

License granted to EnteroBiotix for manufacture of microbiome product candidates

Clinical Microbiomics expanding with €10M million investment

Novome Biotechnologies raises $43.5M for therapeutically engineered microbes pipeline

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!